Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C031903 |
1-UFT protocol |
HRAS protein results in decreased susceptibility to 1-UFT protocol | decreases response to substance | 16734730
|
C016403 |
2,4-dinitrotoluene |
2,4-dinitrotoluene affects the expression of HRAS mRNA | affects expression | 21346803
|
C023514 |
2,6-dinitrotoluene |
2,6-dinitrotoluene affects the expression of HRAS mRNA | affects expression | 21346803
|
C004726 |
2-dichlorobenzene |
2-dichlorobenzene results in increased expression of HRAS mRNA | increases expression | 10614693
|
C024836 |
4-nitrophenol |
HRAS protein affects the glucuronidation of 4-nitrophenol | affects glucuronidation | 11695553
|
C080417 |
4-octylphenol |
4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | affects reaction|increases response to substance | 12117780
|
D000111 |
Acetylcysteine |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 15945272
|
D000244 |
Adenosine Diphosphate |
Adenosine Diphosphate binds to and affects the folding of HRAS protein | affects binding|affects folding | 16388579
|
D016604 |
Aflatoxin B1 |
Aflatoxin B1 affects the expression of HRAS protein | affects expression | 20106945
|
C006632 |
arsenic trioxide |
[Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18922899
|
C018003 |
benzo(a)pyrene-3,6-quinone |
benzo(a)pyrene-3,6-quinone results in increased expression of HRAS mRNA | increases expression | 11008122
|
C017228 |
benzo(a)pyrene 7,8-dihydrodiol |
benzo(a)pyrene 7,8-dihydrodiol results in increased expression of HRAS mRNA | increases expression | 11008122
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene metabolite results in increased expression of HRAS mRNA | increases expression | 11008122
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HRAS mRNA | increases expression | 11008122
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HRAS mRNA | increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HRAS protein | increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HRAS mRNA | increases expression | 20064080 19408242
|
D001564 |
Benzo(a)pyrene |
Benzo(a)pyrene results in increased expression of HRAS protein | increases expression | 20064080 19408242
|
D001564 |
Benzo(a)pyrene |
[Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 19408242
|
D001564 |
Benzo(a)pyrene |
[Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS protein | affects cotreatment|increases expression | 19408242
|
D001564 |
Benzo(a)pyrene |
Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | increases expression|increases reaction | 20064080
|
D001564 |
Benzo(a)pyrene |
Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | increases expression|increases reaction | 20064080
|
D001608 |
Beryllium |
Beryllium results in increased mutagenesis of HRAS gene | increases mutagenesis | 7545909
|
C477843 |
bicyclol |
bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 17106253
|
D002084 |
Butylated Hydroxytoluene |
Butylated Hydroxytoluene results in decreased methylation of HRAS gene | decreases methylation | 9780227
|
D000001 |
Calcimycin |
Calcimycin promotes the reaction [RASGRF2 protein binds to HRAS protein] | affects binding|increases reaction | 16000378
|
C110904 |
capecitabine |
HRAS protein results in decreased susceptibility to capecitabine | decreases response to substance | 16734730
|
D002251 |
Carbon Tetrachloride |
Carbon Tetrachloride results in increased expression of HRAS mRNA | increases expression | 8847708
|
D002713 |
Chlorine |
[Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | affects cotreatment|decreases expression | 18636392
|
D020111 |
Chlorodiphenyl (54% Chlorine) |
Chlorodiphenyl (54% Chlorine) results in increased expression of HRAS mRNA | increases expression | 8471063
|
D003300 |
Copper |
[N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | affects cotreatment|increases mutagenesis | 11275476
|
C061481 |
dibenzoylmethane |
dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 16051634
|
D002945 |
Cisplatin |
Cisplatin results in increased expression of HRAS mRNA | increases expression | 18172885
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
4-octylphenol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | affects reaction|increases response to substance | 12117780
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | affects reaction|increases response to substance | 12117780
|
D015127 |
9,10-Dimethyl-1,2-benzanthracene |
HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene | increases response to substance | 12117780 11376698
|
C067311 |
docetaxel |
docetaxel results in increased expression of and results in increased activity of HRAS protein | increases activity|increases expression | 15970518
|
C025034 |
doxifluridine |
HRAS protein results in decreased susceptibility to doxifluridine | decreases response to substance | 16734730
|
D004317 |
Doxorubicin |
Doxorubicin results in increased expression of HRAS mRNA | increases expression | 16001973
|
C062669 |
epicatechin gallate |
epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
C062669 |
epicatechin gallate |
epicatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
C045651 |
epigallocatechin gallate |
epigallocatechin gallate inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
C500988 |
estradiol-3,4-quinone |
estradiol-3,4-quinone results in increased mutagenesis of HRAS gene | increases mutagenesis | 17261777
|
D004958 |
Estradiol |
dibenzoylmethane inhibits the reaction [Estradiol results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 16051634
|
D004958 |
Estradiol |
Estradiol affects the reaction [HRAS protein results in increased susceptibility to 9,10-Dimethyl-1,2-benzanthracene] | affects reaction|increases response to substance | 12117780
|
D004958 |
Estradiol |
Estradiol results in increased expression of HRAS mRNA | increases expression | 16051634
|
D004967 |
Estrogens |
[Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18204794
|
D004967 |
Estrogens |
[Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18204794
|
D005038 |
Ethylnitrosourea |
HRAS protein results in increased susceptibility to Ethylnitrosourea | increases response to substance | 11182032
|
C093323 |
farnesylthiosalicylic acid |
farnesylthiosalicylic acid results in decreased activity of HRAS protein | decreases activity | 15328380
|
C093323 |
farnesylthiosalicylic acid |
farnesylthiosalicylic acid results in decreased expression of HRAS protein | decreases expression | 16780807
|
C020748 |
ferrous sulfate |
ferrous sulfate affects the localization of HRAS protein | affects localization | 17172471
|
C020748 |
ferrous sulfate |
ferrous sulfate promotes the reaction [MAP3K7 protein binds to HRAS protein binds to PIK3R1 protein] | affects binding|increases reaction | 17172471
|
C020748 |
ferrous sulfate |
HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471
|
C020748 |
ferrous sulfate |
HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471
|
C020748 |
ferrous sulfate |
HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 17172471
|
C020748 |
ferrous sulfate |
HRAS protein affects the reaction [ferrous sulfate results in increased phosphorylation of NFKBIA protein] | affects reaction|increases phosphorylation | 17172471
|
D015073 |
2-Acetylaminofluorene |
2-Acetylaminofluorene results in increased expression of HRAS protein | increases expression | 11350689
|
D005472 |
Fluorouracil |
Fluorouracil results in increased expression of HRAS mRNA | increases expression | 16557594
|
D005480 |
Flurbiprofen |
HRAS protein affects the reaction [Flurbiprofen results in increased expression of PSCA mRNA] | affects reaction|increases expression | 16949054
|
D005947 |
Glucose |
Glucose results in increased activity of HRAS protein | increases activity | 16572112
|
D005947 |
Glucose |
manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | decreases reaction|increases activity | 16572112
|
D017127 |
Glycosylation End Products, Advanced |
Glycosylation End Products, Advanced results in increased activity of HRAS protein | increases activity | 16572112
|
D017127 |
Glycosylation End Products, Advanced |
manumycin inhibits the reaction [Glycosylation End Products, Advanced results in increased activity of HRAS protein] | decreases reaction|increases activity | 16572112
|
D006533 |
Heptachlor |
Heptachlor results in decreased expression of HRAS mRNA | decreases expression | 1771636
|
D006861 |
Hydrogen Peroxide |
Hydrogen Peroxide results in increased expression of HRAS mRNA | increases expression | 11008122
|
D007501 |
Iron |
HRAS protein affects the reaction [Iron results in increased phosphorylation of AKT1 protein] | affects reaction|increases phosphorylation | 17172471
|
D007501 |
Iron |
HRAS protein affects the reaction [Iron results in increased phosphorylation of MAPK1 protein] | affects reaction|increases phosphorylation | 17172471
|
D007501 |
Iron |
HRAS protein affects the reaction [Iron results in increased phosphorylation of MAPK3 protein] | affects reaction|increases phosphorylation | 17172471
|
D007501 |
Iron |
HRAS protein affects the reaction [Iron results in increased phosphorylation of NFKBIA protein] | affects reaction|increases phosphorylation | 17172471
|
D007501 |
Iron |
Iron affects the localization of HRAS protein | affects localization | 17172471
|
D007501 |
Iron |
Iron promotes the reaction [MAP3K7 protein binds to HRAS protein binds to PIK3R1 protein] | affects binding|increases reaction | 17172471
|
D007854 |
Lead |
Lead inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | affects binding|decreases reaction | 15111246
|
C008261 |
lead acetate |
lead acetate inhibits the reaction [HSPA5 protein binds to HRAS enhancer] | affects binding|decreases reaction | 15111246
|
C008281 |
limonene |
limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | decreases reaction|increases response to substance | 11802805
|
C115354 |
lonafarnib |
lonafarnib inhibits the reaction [TNF protein results in increased activity of HRAS protein] | decreases reaction|increases activity | 15090542
|
D008294 |
Malathion |
[Malathion co-treated with Estrogens] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18204794
|
D008294 |
Malathion |
Malathion results in increased expression of HRAS mRNA | increases expression | 18204794
|
C054474 |
manumycin |
manumycin inhibits the reaction [Glucose results in increased activity of HRAS protein] | decreases reaction|increases activity | 16572112
|
C054474 |
manumycin |
manumycin inhibits the reaction [Glycosylation End Products, Advanced results in increased activity of HRAS protein] | decreases reaction|increases activity | 16572112
|
D008627 |
Mercuric Chloride |
Mercuric Chloride promotes the reaction [HSPA5 protein binds to HRAS enhancer] | affects binding|increases reaction | 15111246
|
D008628 |
Mercury |
Mercury promotes the reaction [HSPA5 protein binds to HRAS enhancer] | affects binding|increases reaction | 15111246
|
D008770 |
Methylnitrosourea |
HRAS protein results in increased susceptibility to Methylnitrosourea | increases response to substance | 11376698 12117780 11802805 11182032
|
D008770 |
Methylnitrosourea |
limonene inhibits the reaction [HRAS protein results in increased susceptibility to Methylnitrosourea] | decreases reaction|increases response to substance | 11802805
|
D008770 |
Methylnitrosourea |
HRAS protein results in decreased susceptibility to Methylnitrosourea | decreases response to substance | 11973638
|
D008770 |
Methylnitrosourea |
Methylnitrosourea results in increased mutagenesis of HRAS gene | increases mutagenesis | 10767621 15688392
|
C014593 |
N-hydroxy-4-aminobiphenyl |
[N-hydroxy-4-aminobiphenyl co-treated with Copper] results in increased mutagenesis of HRAS gene | affects cotreatment|increases mutagenesis | 11275476
|
D009538 |
Nicotine |
Nicotine results in increased activity of HRAS protein | increases activity | 15983034
|
D009583 |
Nitrofurazone |
Acetylcysteine inhibits the reaction [Nitrofurazone results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 15945272
|
D009583 |
Nitrofurazone |
Nitrofurazone results in increased expression of HRAS mRNA | increases expression | 15945272
|
D009705 |
Nucleosides |
Nucleosides results in increased expression of HRAS mRNA | increases expression | 15173389
|
D010126 |
Ozone |
[Ozone co-treated with Chlorine] results in decreased expression of HRAS mRNA | affects cotreatment|decreases expression | 18636392
|
D010278 |
Parathion |
[Parathion co-treated with Estrogens] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18204794
|
D011005 |
Plutonium |
Plutonium results in increased mutagenesis of HRAS gene | increases mutagenesis | 9255578
|
D011794 |
Quercetin |
Quercetin results in decreased expression of HRAS mRNA | decreases expression | 10652438
|
D011794 |
Quercetin |
Quercetin results in decreased expression of HRAS protein | decreases expression | 10652438
|
C059514 |
resveratrol |
resveratrol affects the expression of HRAS mRNA mutant form | affects expression | 16369916
|
C059514 |
resveratrol |
resveratrol affects the expression of HRAS protein mutant form | affects expression | 16369916
|
D012402 |
Rotenone |
Rotenone results in decreased expression of HRAS mRNA | decreases expression | 10630619
|
C079198 |
S 1 (combination) |
HRAS protein results in decreased susceptibility to S 1 (combination) | decreases response to substance | 16734730
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 19244175
|
D012643 |
Selenium |
Selenium results in increased expression of HRAS mRNA | increases expression | 19244175
|
D017632 |
Asbestos, Serpentine |
Asbestos, Serpentine results in increased expression of HRAS protein | increases expression | 10905503
|
D017632 |
Asbestos, Serpentine |
tobacco tar promotes the reaction [Asbestos, Serpentine results in increased expression of HRAS protein] | increases expression|increases reaction | 10905503
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HRAS mRNA | increases expression | 19464579
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HRAS protein | increases expression | 16039940
|
C017947 |
sodium arsenite |
sodium arsenite results in decreased expression of HRAS mRNA | decreases expression | 19822182
|
C017947 |
sodium arsenite |
sodium arsenite results in increased expression of HRAS mRNA | increases expression | 16876216 11241755
|
D013458 |
Sulfur Dioxide |
[Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 19408242
|
D013458 |
Sulfur Dioxide |
[Sulfur Dioxide co-treated with Benzo(a)pyrene] results in increased expression of HRAS protein | affects cotreatment|increases expression | 19408242
|
D013458 |
Sulfur Dioxide |
Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | increases expression|increases reaction | 20064080
|
D013458 |
Sulfur Dioxide |
Sulfur Dioxide promotes the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | increases expression|increases reaction | 20064080
|
D013458 |
Sulfur Dioxide |
Sulfur Dioxide results in increased expression of HRAS mRNA | increases expression | 19408242 20064080
|
D013458 |
Sulfur Dioxide |
Sulfur Dioxide results in increased expression of HRAS protein | increases expression | 20064080 19408242
|
C452601 |
sulindac derivative IND 12 |
HRAS protein affects the reaction [sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK1 protein] | affects reaction|decreases activity|decreases phosphorylation | 11912145
|
C452601 |
sulindac derivative IND 12 |
HRAS protein affects the reaction [sulindac derivative IND 12 results in decreased phosphorylation of and results in decreased activity of MAPK3 protein] | affects reaction|decreases activity|decreases phosphorylation | 11912145
|
D013481 |
Superoxides |
HRAS protein mutant form results in increased abundance of Superoxides | increases abundance | 11313892
|
D013481 |
Superoxides |
[HRAS protein mutant form results in increased abundance of Superoxides] which results in decreased susceptibility to TNF protein | decreases response to substance|increases abundance | 11313892
|
D013755 |
Tetradecanoylphorbol Acetate |
[Tetradecanoylphorbol Acetate co-treated with arsenic trioxide] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 18922899
|
D013755 |
Tetradecanoylphorbol Acetate |
bicyclol inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 17106253
|
D013755 |
Tetradecanoylphorbol Acetate |
Tetradecanoylphorbol Acetate results in increased expression of HRAS mRNA | increases expression | 17106253
|
D013774 |
Tetranitromethane |
Tetranitromethane results in increased mutagenesis of HRAS gene | increases mutagenesis | 9255578
|
C056068 |
theaflavin |
theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS mRNA] | decreases reaction|increases expression | 18973830
|
C056068 |
theaflavin |
theaflavin inhibits the reaction [Benzo(a)pyrene results in increased expression of HRAS protein] | decreases reaction|increases expression | 18973830
|
C402769 |
tipifarnib |
HRAS gene mutant form results in increased susceptibility to tipifarnib | increases response to substance | 16403772 16648579
|
C402769 |
tipifarnib |
tipifarnib results in decreased activity of HRAS protein | decreases activity | 15970518
|
C024746 |
tobacco tar |
tobacco tar promotes the reaction [Asbestos, Serpentine results in increased expression of HRAS protein] | increases expression|increases reaction | 10905503
|
D014520 |
Urethane |
HRAS protein promotes the reaction [Urethane results in increased expression of CCND1 protein] | increases expression|increases reaction | 11307925
|
D014520 |
Urethane |
HRAS protein results in increased susceptibility to Urethane | increases response to substance | 11552296 10779650
|
D014520 |
Urethane |
Urethane results in increased mutagenesis of HRAS gene | increases mutagenesis | 10779650 12765245
|
D001335 |
Vehicle Emissions |
HRAS protein results in increased susceptibility to Vehicle Emissions | increases response to substance | 11516524
|
D014750 |
Vincristine |
Vincristine results in increased expression of HRAS mRNA | increases expression | 16001973
|
C017963 |
vinyl carbamate |
vinyl carbamate results in increased mutagenesis of HRAS gene | increases mutagenesis | 12765245
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in increased expression of HRAS mRNA | affects cotreatment|increases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in increased expression of HRAS mRNA | increases expression | 19244175
|
C088658 |
zoledronic acid |
zoledronic acid results in decreased localization of HRAS protein | decreases localization | 11986784
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D058186 |
Acute Kidney Injury |
|
Cisplatin |
19.64 | 15814532 12690470 17670903 |
MESH:D058186 |
Acute Kidney Injury |
|
Mercuric Chloride |
19.64 | 11274264 |
MESH:D058186 |
Acute Kidney Injury |
|
resveratrol |
19.64 | 16538975 |
MESH:D058186 |
Acute Kidney Injury |
|
Superoxides |
19.64 | 18460982 |
MESH:D058186 |
Acute Kidney Injury |
|
zoledronic acid |
19.64 | 19715164 |
MESH:D055371 |
Acute Lung Injury |
|
Chlorine |
3.62 | 20601635 |
MESH:D000210 |
Acute-Phase Reaction |
|
zoledronic acid |
4.72 | 20200999 |
MESH:D000230 |
Adenocarcinoma |
|
9,10-Dimethyl-1,2-benzanthracene |
30.42 | 10697514 12844480 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
30.42 | 11798837 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
Benzo(a)pyrene |
30.42 | 20127859 20464547 |
MESH:D000230 |
Adenocarcinoma |
|
Cisplatin |
30.42 | 11798837 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Doxorubicin |
30.42 | 17418594 |
MESH:D000230 |
Adenocarcinoma |
|
Estradiol |
30.42 | 11473722 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
30.42 | 17638652 |
MESH:D000230 |
Adenocarcinoma |
|
Methylnitrosourea |
30.42 | 15688392 15113128 |
MESH:D000230 |
Adenocarcinoma |
|
Urethane |
30.42 | 18316556 |
MESH:D000230 |
Adenocarcinoma |
|
Vincristine |
30.42 | 19825857 |
MESH:D000230 |
Adenocarcinoma |
|
vinyl carbamate |
30.42 | 17363558 16247444 |
MESH:D002282 |
Adenocarcinoma, Bronchiolo-Alveolar |
|
Urethane |
4.93 | 15814487 |
MESH:D000236 |
Adenoma |
|
2-Acetylaminofluorene |
19.81 | 10737359 |
MESH:D000236 |
Adenoma |
|
9,10-Dimethyl-1,2-benzanthracene |
19.81 | 11376689 |
MESH:D000236 |
Adenoma |
|
Benzo(a)pyrene |
19.81 | 6695378 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
19.81 | 6695378 |
MESH:D000236 |
Adenoma |
|
resveratrol |
19.81 | 15688382 |
MESH:D000236 |
Adenoma |
|
Urethane |
19.81 | 10822126 17195641 16926031 11497255 6695378 17093202 10530776 |
MESH:D002759 |
Adenoma, Bile Duct |
|
2-Acetylaminofluorene |
5.23 | 6705139 |
MESH:D018248 |
Adenoma, Liver Cell |
|
vinyl carbamate |
4.86 | 12371669 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
dibenzoylmethane |
8.48 | 17942926 |
MESH:D011125 |
Adenomatous Polyposis Coli |
|
Flurbiprofen |
8.48 | 10680582 |
MESH:D000310 |
Adrenal Gland Neoplasms |
|
sodium arsenite |
3.92 | 15276417 |
MESH:D018246 |
Adrenocortical Adenoma |
|
sodium arsenite |
4.12 | 17306315 16712894 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Heptachlor |
10.56 | 12661182 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Malathion |
10.56 | 17119214 11874814 |
MESH:D000382 |
Agricultural Workers' Diseases |
|
Parathion |
10.56 | 11874814 17119214 |
MESH:D000419 |
Albuminuria |
|
Doxorubicin |
3.81 | 21441931 |
MESH:D019896 |
alpha 1-Antitrypsin Deficiency |
|
Iron |
4.89 | 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Copper |
9.86 | 16866297 16325427 16410023 17119284 16886094 16962711 |
MESH:D000544 |
Alzheimer Disease |
|
Iron |
9.86 | 16563566 16640825 |
MESH:D000544 |
Alzheimer Disease |
|
Nicotine |
9.86 | 16627626 |
MESH:D000544 |
Alzheimer Disease |
|
Ozone |
9.86 | 15513908 |
MESH:D000544 |
Alzheimer Disease |
|
resveratrol |
9.86 | 16162502 16183991 |
MESH:D000690 |
Amyotrophic Lateral Sclerosis |
|
Copper |
3.77 | 10694572 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
6.97 | 16511603 17963324 15504547 |
MESH:D000740 |
Anemia |
|
Iron |
6.97 | 16434484 16566752 |
MESH:D000743 |
Anemia, Hemolytic |
|
Quercetin |
3.55 | 17084956 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Copper |
8.23 | 16614410 |
MESH:D018798 |
Anemia, Iron-Deficiency |
|
Iron |
8.23 | 16569441 17147795 17162259 17375513 17163184 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Iron |
8.95 | 16910769 |
MESH:D000756 |
Anemia, Sideroblastic |
|
Superoxides |
8.95 | 16910769 |
MESH:D017544 |
Aortic Aneurysm, Abdominal |
|
Benzo(a)pyrene |
3.33 | 19183758 |
MESH:D001145 |
Arrhythmias, Cardiac |
|
Iron |
3.70 | 16604332 |
MESH:D001169 |
Arthritis, Experimental |
|
resveratrol |
2.99 | 17115116 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Ozone |
2.33 | 15570426 |
MESH:D001195 |
Asbestosis |
|
Asbestos, Serpentine |
4.94 | 10751356 |
MESH:D001249 |
Asthma |
|
epigallocatechin gallate |
4.30 | 16516891 |
MESH:D001249 |
Asthma |
|
Ozone |
4.30 | 16373670 17854713 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Iron |
10.57 | 15336622 |
MESH:D001260 |
Ataxia Telangiectasia |
|
Quercetin |
10.57 | 15336622 |
MESH:D050197 |
Atherosclerosis |
|
Iron |
5.38 | 16640825 16632123 |
MESH:D050197 |
Atherosclerosis |
|
resveratrol |
5.38 | 17967414 16873680 |
MESH:D001321 |
Autistic Disorder |
marker/mechanism |
|
| 8098541 |
MESH:D001321 |
Autistic Disorder |
|
Iron |
2.68 | 17352947 |
MESH:D001321 |
Autistic Disorder |
|
Mercury |
2.68 | 17497416 |
MESH:D001327 |
Autoimmune Diseases |
|
epigallocatechin gallate |
13.93 | 19761891 |
MESH:D001327 |
Autoimmune Diseases |
|
Mercury |
13.93 | 16634805 |
MESH:D001327 |
Autoimmune Diseases |
|
Quercetin |
13.93 | 19761891 |
MESH:D001424 |
Bacterial Infections |
|
Iron |
4.43 | 16640825 |
MESH:D001607 |
Berylliosis |
|
Beryllium |
5.41 | 19589099 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
7.49 | 16206674 |
MESH:D001778 |
Blood Coagulation Disorders |
|
ferrous sulfate |
7.49 | 6421970 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Cisplatin |
9.47 | 14601052 |
MESH:D019046 |
Bone Marrow Neoplasms |
|
Doxorubicin |
9.47 | 14601052 |
MESH:D001859 |
Bone Neoplasms |
|
zoledronic acid |
4.25 | 16778634 11697798 15867366 19442620 17312309 16121404 |
MESH:D001862 |
Bone Resorption |
|
zoledronic acid |
4.01 | 15845617 8053405 18404659 16769263 11869084 18496637 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
4.20 | 14991843 |
MESH:D002545 |
Brain Ischemia |
|
resveratrol |
3.53 | 17600658 |
MESH:D001932 |
Brain Neoplasms |
|
Copper |
10.98 | 17079463 |
MESH:D001932 |
Brain Neoplasms |
|
Doxorubicin |
10.98 | 17150277 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
10.98 | 16651633 15144691 16436596 18412241 16357521 |
MESH:D001943 |
Breast Neoplasms |
marker/mechanism |
|
| 17474063 15958052 |
MESH:D001943 |
Breast Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
13.40 | 20435547 17127718 18840765 15565634 16153821 |
MESH:D001943 |
Breast Neoplasms |
|
Benzo(a)pyrene |
13.40 | 17474063 20146248 |
MESH:D001943 |
Breast Neoplasms |
|
capecitabine |
13.40 | 12972520 18473752 |
MESH:D001943 |
Breast Neoplasms |
|
Cisplatin |
13.40 | 18382427 19526202 |
MESH:D001943 |
Breast Neoplasms |
|
Copper |
13.40 | 17079463 15986119 |
MESH:D001943 |
Breast Neoplasms |
|
docetaxel |
13.40 | 16495393 18628466 15567936 16264153 15692762 19526202 17369602 |
MESH:D001943 |
Breast Neoplasms |
|
Doxorubicin |
13.40 | 15939500 15993339 18628466 17369602 16096432 16322301 18695136 18382427 15136595 15567936 16264153 18234424 19526202 15634643 11325840 15692762 17426702 17983394 16935488 15994142 16115903 16826403 16595493 15668708 |
MESH:D001943 |
Breast Neoplasms |
|
Estradiol |
13.40 | 17289903 14630087 12948864 17018787 17261762 16675129 19861407 18497071 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
13.40 | 19217205 16595493 15136595 18357371 18608205 16110121 16557594 |
MESH:D001943 |
Breast Neoplasms |
|
Heptachlor |
13.40 | 8738476 |
MESH:D001943 |
Breast Neoplasms |
|
Malathion |
13.40 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Methylnitrosourea |
13.40 | 16253758 14633655 11306469 |
MESH:D001943 |
Breast Neoplasms |
|
Parathion |
13.40 | 12762645 |
MESH:D001943 |
Breast Neoplasms |
|
Quercetin |
13.40 | 18628248 |
MESH:D001943 |
Breast Neoplasms |
|
resveratrol |
13.40 | 16393696 17651959 17534123 |
MESH:D001943 |
Breast Neoplasms |
|
zoledronic acid |
13.40 | 18695136 16096432 |
MESH:D016535 |
Bronchial Hyperreactivity |
|
Ozone |
3.06 | 18315731 14754758 15516495 19059883 18417511 16777450 17626835 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
3.62 | 11589617 |
MESH:D002100 |
Cachexia |
|
Ozone |
3.98 | 16183385 |
MESH:D002105 |
Cadmium Poisoning |
|
Quercetin |
4.77 | 16962696 |
MESH:D002181 |
Candidiasis, Vulvovaginal |
|
Estradiol |
3.70 | 16111702 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Carbon Tetrachloride |
7.46 | 16050911 15700767 16011737 16124888 18705752 16227642 16097048 15673190 16192424 15721981 3786805 10355542 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
7.46 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Doxorubicin |
9.77 | 16051944 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
9.77 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
2.95 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
marker/mechanism |
|
| 9311599 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,4-dinitrotoluene |
33.26 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2,6-dinitrotoluene |
33.26 | 16705839 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
2-Acetylaminofluorene |
33.26 | 17761372 6705139 3084413 10737359 3581430 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Aflatoxin B1 |
33.26 | 12907637 21507988 12619106 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
33.26 | 15553829 14691202 11135700 16217749 15073043 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Carbon Tetrachloride |
33.26 | 18788625 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Cisplatin |
33.26 | 17982673 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Doxorubicin |
33.26 | 18059187 16234567 16023760 17876044 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estradiol |
33.26 | 16924424 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Estrogens |
33.26 | 15341023 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
33.26 | 18930000 16332177 16799960 17045692 17971768 17088986 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Quercetin |
33.26 | 12508355 19519916 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
resveratrol |
33.26 | 19321006 16227395 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
sodium arsenite |
33.26 | 15276417 17306315 16507464 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
vinyl carbamate |
33.26 | 12371669 |
MESH:D018827 |
Carcinoma, Lewis Lung |
|
resveratrol |
3.83 | 16675471 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
Cisplatin |
13.20 | 16685392 12023789 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
docetaxel |
13.20 | 11894018 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
S 1 (combination) |
13.20 | 18212800 18347146 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
vinyl carbamate |
13.20 | 16247446 |
MESH:D002289 |
Carcinoma, Non-Small-Cell Lung |
|
zoledronic acid |
13.20 | 19233551 |
MESH:D021441 |
Carcinoma, Pancreatic Ductal |
|
Quercetin |
4.21 | 17234771 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
4.09 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Doxorubicin |
11.94 | 16201981 1485588 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
11.94 | 18695887 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Vincristine |
11.94 | 16201981 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
zoledronic acid |
11.94 | 18507039 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
3.44 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
9,10-Dimethyl-1,2-benzanthracene |
31.52 | 11376689 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Acetylcysteine |
31.52 | 17015178 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Benzo(a)pyrene |
31.52 | 20419170 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Cisplatin |
31.52 | 17066447 18337622 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Doxorubicin |
31.52 | 6189445 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
31.52 | 18986760 16280240 16757204 17066447 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
resveratrol |
31.52 | 16227395 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
S 1 (combination) |
31.52 | 15984520 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
sodium arsenite |
31.52 | 18572023 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Tetradecanoylphorbol Acetate |
31.52 | 18922899 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Vincristine |
31.52 | 6189445 |
MESH:C535579 |
Cardiofaciocutaneous syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D006332 |
Cardiomegaly |
|
Copper |
5.80 | 17327471 |
MESH:D006332 |
Cardiomegaly |
|
Quercetin |
5.80 | 19794523 |
MESH:D009202 |
Cardiomyopathies |
|
Doxorubicin |
6.34 | 17928571 16364871 17382496 16651473 17007740 16455267 16952015 15505089 16612575 18627295 16278810 17329180 17974986 15476868 17924179 16269455 16242529 17519947 15811867 17351982 16731534 16109756 15792986 17308081 17131338 |
MESH:D009202 |
Cardiomyopathies |
|
Iron |
6.34 | 16640825 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Doxorubicin |
7.73 | 17334414 16243910 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Iron |
7.73 | 16604332 |
MESH:D002311 |
Cardiomyopathy, Dilated |
|
Mercury |
7.73 | 10334427 |
MESH:D002318 |
Cardiovascular Diseases |
|
Hydrogen Peroxide |
5.71 | 16936243 |
MESH:D002318 |
Cardiovascular Diseases |
|
resveratrol |
5.71 | 15458977 |
MESH:D002386 |
Cataract |
|
Methylnitrosourea |
3.49 | 12484553 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
2,6-dinitrotoluene |
27.48 | 6135515 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Acetylcysteine |
27.48 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Estradiol |
27.48 | 18566989 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
estradiol-3,4-quinone |
27.48 | 18226522 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
27.48 | 16003739 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Methylnitrosourea |
27.48 | 2727394 7505956 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
sodium arsenite |
27.48 | 19524636 20056578 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
tobacco tar |
27.48 | 19559774 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
5.20 | 17160924 |
MESH:D014355 |
Chagas Disease |
|
Nitrofurazone |
6.40 | 11354658 |
MESH:D002972 |
Cleft Palate |
|
Urethane |
3.39 | 12810352 |
MESH:D003092 |
Colitis |
|
resveratrol |
7.19 | 16474422 |
MESH:D003092 |
Colitis |
|
Selenium |
7.19 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
6.55 | 16340194 15001691 17018589 17725105 17016597 16510598 18772588 17172411 17169374 17287894 |
MESH:D003110 |
Colonic Neoplasms |
|
Iron |
6.55 | 16640825 |
MESH:D003110 |
Colonic Neoplasms |
|
Quercetin |
6.55 | 17148506 19056647 19440933 16640504 11134977 15741050 17191121 |
MESH:D003110 |
Colonic Neoplasms |
|
resveratrol |
6.55 | 16338953 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
8.57 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
capecitabine |
8.57 | 18473752 18448328 |
MESH:D015179 |
Colorectal Neoplasms |
|
Cisplatin |
8.57 | 15273666 |
MESH:D015179 |
Colorectal Neoplasms |
|
Doxorubicin |
8.57 | 18259882 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
8.57 | 17016601 17401013 16391804 17695437 18448328 18383874 18288408 16303861 14970324 17454858 18949393 15148649 17094418 16524972 17594712 16331619 15289873 18509181 17255274 16282729 20501625 18802399 |
MESH:D015179 |
Colorectal Neoplasms |
|
Quercetin |
8.57 | 18852136 18095365 |
MESH:D015179 |
Colorectal Neoplasms |
|
resveratrol |
8.57 | 16550006 |
MESH:D003327 |
Coronary Disease |
|
resveratrol |
3.21 | 16507316 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
3.46 | 12609071 |
MESH:D003329 |
Coronary Vasospasm |
|
capecitabine |
5.08 | 17465463 |
MESH:D056685 |
Costello Syndrome |
marker/mechanism |
|
| 17468812 19132118 17703371 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
4.47 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Lead |
4.47 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
lead acetate |
4.47 | 19769572 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
4.47 | 19769572 |
MESH:D016638 |
Critical Illness |
|
Estrogens |
5.18 | 16670151 |
MESH:D003490 |
Cyanosis |
|
2,4-dinitrotoluene |
8.42 | 18551238 |
MESH:D003490 |
Cyanosis |
|
2,6-dinitrotoluene |
8.42 | 18551238 |
MESH:D003550 |
Cystic Fibrosis |
|
Acetylcysteine |
3.71 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
4.03 | 16733453 |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
3.38 | 15213294 |
MESH:D003704 |
Dementia |
|
Lead |
4.56 | 16140633 |
MESH:D017449 |
Dermatitis, Allergic Contact |
|
Mercury |
3.11 | 16823706 |
MESH:D048909 |
Diabetes Complications |
|
Glycosylation End Products, Advanced |
5.85 | 19471234 |
MESH:D003920 |
Diabetes Mellitus |
|
Iron |
3.80 | 16640825 16604332 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
Quercetin |
6.43 | 19496084 |
MESH:D003921 |
Diabetes Mellitus, Experimental |
|
resveratrol |
6.43 | 16873680 |
MESH:D003922 |
Diabetes Mellitus, Type 1 |
|
Iron |
3.06 | 16506275 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
epigallocatechin gallate |
4.27 | 16988119 |
MESH:D003924 |
Diabetes Mellitus, Type 2 |
|
Iron |
4.27 | 16506275 |
MESH:D003928 |
Diabetic Nephropathies |
|
Estradiol |
6.84 | 19279558 |
MESH:D003928 |
Diabetic Nephropathies |
|
resveratrol |
6.84 | 16286809 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,4-dinitrotoluene |
19.70 | 21346803 18551238 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
2,6-dinitrotoluene |
19.70 | 18551238 21346803 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Acetylcysteine |
19.70 | 11287661 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
bicyclol |
19.70 | 15998439 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Carbon Tetrachloride |
19.70 | 16177239 6884620 10915739 15998439 15968718 10092053 9327722 11566570 17522070 6623471 2869522 7179309 16227642 15027814 7440962 19336974 21278145 7120509 19085960 3732212 4309450 3786805 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Chlorodiphenyl (54% Chlorine) |
19.70 | 17851650 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Doxorubicin |
19.70 | 17416283 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
manumycin |
19.70 | 19739265 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
19.70 | 15131321 |
MESH:D004362 |
Drug Toxicity |
|
Cisplatin |
6.53 | 12649298 19839026 15033597 12231392 |
MESH:D004362 |
Drug Toxicity |
|
Doxorubicin |
6.53 | 18602426 |
MESH:D004417 |
Dyspnea |
|
Chlorine |
3.85 | 20016425 |
MESH:D020821 |
Dystonic Disorders |
|
Nicotine |
5.16 | 17881519 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
3.92 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
5.20 | 18357618 |
MESH:D004487 |
Edema |
|
resveratrol |
5.10 | 8985016 |
MESH:D004487 |
Edema |
|
Tetradecanoylphorbol Acetate |
5.10 | 11698051 8113982 15177302 7812673 16716910 9599246 8273558 |
MESH:D004681 |
Encephalomyelitis, Autoimmune, Experimental |
|
resveratrol |
3.31 | 17872969 |
MESH:D016889 |
Endometrial Neoplasms |
|
Doxorubicin |
5.73 | 17359293 |
MESH:D016889 |
Endometrial Neoplasms |
|
Estradiol |
5.73 | 19148513 11473722 18566989 |
MESH:D004719 |
Endomyocardial Fibrosis |
|
Doxorubicin |
4.38 | 18037988 |
MESH:D020345 |
Enterocolitis, Necrotizing |
|
resveratrol |
4.10 | 17923197 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
10.87 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Benzo(a)pyrene |
10.87 | 16530937 |
MESH:D004938 |
Esophageal Neoplasms |
|
Cisplatin |
10.87 | 16785472 15464296 17638652 15173087 16481741 |
MESH:D004938 |
Esophageal Neoplasms |
|
docetaxel |
10.87 | 16337965 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
10.87 | 16337965 16785472 15173087 17638652 16481741 |
MESH:D020329 |
Essential Tremor |
|
Lead |
5.16 | 14594619 18007985 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
13.33 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
bicyclol |
13.33 | 16409862 |
MESH:D005234 |
Fatty Liver |
|
Carbon Tetrachloride |
13.33 | 16239168 12795759 61145 12631006 19224547 15959796 16045604 17595544 |
MESH:D005234 |
Fatty Liver |
|
Iron |
13.33 | 16640825 |
MESH:D005264 |
Femoral Fractures |
|
zoledronic acid |
5.06 | 16234978 |
MESH:D005317 |
Fetal Growth Retardation |
|
Lead |
9.29 | 19769572 |
MESH:D005317 |
Fetal Growth Retardation |
|
lead acetate |
9.29 | 19769572 |
MESH:D018222 |
Fibromatosis, Aggressive |
|
Doxorubicin |
3.83 | 19069698 |
MESH:D005354 |
Fibrosarcoma |
|
Methylnitrosourea |
4.47 | 11555667 |
MESH:D005355 |
Fibrosis |
|
Carbon Tetrachloride |
6.49 | 18705752 |
MESH:D005355 |
Fibrosis |
|
Quercetin |
6.49 | 19474275 |
MESH:D005621 |
Friedreich Ataxia |
|
Iron |
4.68 | 16604332 16640825 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
9.36 | 16904648 |
MESH:D005706 |
Gallbladder Neoplasms |
|
S 1 (combination) |
9.36 | 19093184 |
MESH:D005739 |
Gas Poisoning |
|
Chlorine |
4.23 | 20016425 |
MESH:D005833 |
Genital Neoplasms, Female |
|
sodium arsenite |
3.91 | 16452187 |
MESH:D005909 |
Glioblastoma |
|
Doxorubicin |
8.91 | 17150277 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
8.91 | 16436596 |
MESH:D005909 |
Glioblastoma |
|
Quercetin |
8.91 | 19804834 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
11.05 | 16651633 16357521 18412241 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
11.05 | 16145905 |
MESH:D005910 |
Glioma |
|
Methylnitrosourea |
11.05 | 9825942 |
MESH:D005910 |
Glioma |
|
Quercetin |
11.05 | 17643826 |
MESH:D006030 |
Glycosuria, Renal |
|
Mercuric Chloride |
5.14 | 2918855 |
MESH:D006099 |
Granuloma |
|
Beryllium |
6.74 | 19070257 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Cisplatin |
13.98 | 15464296 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Doxorubicin |
13.98 | 15692506 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
13.98 | 15162350 18337622 15102660 |
MESH:D006258 |
Head and Neck Neoplasms |
|
S 1 (combination) |
13.98 | 18607998 15984520 |
MESH:D034381 |
Hearing Loss |
|
Cisplatin |
3.64 | 19898482 |
MESH:D006319 |
Hearing Loss, Sensorineural |
|
Cisplatin |
3.77 | 15464296 |
MESH:D006330 |
Heart Defects, Congenital |
|
Benzo(a)pyrene |
5.13 | 20471113 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
5.13 | 16080930 |
MESH:D006331 |
Heart Diseases |
|
Doxorubicin |
6.21 | 16244372 12587719 14766674 16707910 17875725 18674790 16879835 16144979 16495754 16244371 18006777 16330681 17888722 |
MESH:D006331 |
Heart Diseases |
|
Urethane |
6.21 | 16046796 |
MESH:D006333 |
Heart Failure |
|
Doxorubicin |
5.51 | 17481944 |
MESH:D006333 |
Heart Failure |
|
Selenium |
5.51 | 17162251 |
MESH:D006390 |
Hemangioendothelioma |
|
2-Acetylaminofluorene |
4.54 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
2-Acetylaminofluorene |
7.12 | 6705139 |
MESH:D006394 |
Hemangiosarcoma |
|
Doxorubicin |
7.12 | 15692506 |
MESH:D006432 |
Hemochromatosis |
|
Iron |
3.90 | 17255318 16640825 17053826 16574947 16604332 17236123 |
MESH:D006486 |
Hemosiderosis |
|
Iron |
4.44 | 16604332 |
MESH:D006505 |
Hepatitis |
|
Carbon Tetrachloride |
2.87 | 19110552 19900420 |
MESH:D006521 |
Hepatitis, Chronic |
|
Copper |
4.50 | 17338147 |
MESH:D006525 |
Hepatitis, Viral, Human |
|
Iron |
4.69 | 16640825 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Copper |
8.99 | 17109627 17276780 16607473 17182432 19888908 |
MESH:D006527 |
Hepatolenticular Degeneration |
|
Iron |
8.99 | 17182432 |
MESH:D006529 |
Hepatomegaly |
|
Iron |
3.59 | 16890145 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.37 | 16863852 16490937 |
MESH:D006558 |
Herpes Genitalis |
|
Estradiol |
4.25 | 15709030 |
MESH:D006561 |
Herpes Simplex |
|
resveratrol |
3.43 | 16876885 |
MESH:D015658 |
HIV Infections |
|
Iron |
3.22 | 16597321 |
MESH:D006689 |
Hodgkin Disease |
|
Cisplatin |
12.24 | 16200630 16170182 |
MESH:D006689 |
Hodgkin Disease |
|
Doxorubicin |
12.24 | 15147373 18501091 17606976 |
MESH:D006689 |
Hodgkin Disease |
|
sodium arsenite |
12.24 | 12676792 |
MESH:D006689 |
Hodgkin Disease |
|
Vincristine |
12.24 | 17606976 16135485 16794504 15147373 |
MESH:D019584 |
Hot Flashes |
|
Estradiol |
7.48 | 17088409 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
7.48 | 14716179 |
MESH:D006930 |
Hyperalgesia |
|
zoledronic acid |
3.64 | 16769263 |
MESH:D006932 |
Hyperbilirubinemia |
|
Carbon Tetrachloride |
3.77 | 16899240 |
MESH:D006934 |
Hypercalcemia |
|
zoledronic acid |
4.35 | 19622757 18089816 |
MESH:D006937 |
Hypercholesterolemia |
|
resveratrol |
3.32 | 17188708 |
MESH:D006943 |
Hyperglycemia |
|
Quercetin |
3.36 | 11834736 18262572 |
MESH:D020138 |
Hyperhomocysteinemia |
|
Superoxides |
4.61 | 12615666 |
MESH:D006949 |
Hyperlipidemias |
|
resveratrol |
3.33 | 16873680 |
MESH:D006967 |
Hypersensitivity |
|
Butylated Hydroxytoluene |
3.84 | 17604070 |
MESH:D006973 |
Hypertension |
|
Quercetin |
2.52 | 18356687 |
MESH:D006975 |
Hypertension, Portal |
|
Carbon Tetrachloride |
3.34 | 15338365 |
MESH:D017379 |
Hypertrophy, Left Ventricular |
|
resveratrol |
3.63 | 17488730 |
MESH:D006996 |
Hypocalcemia |
|
zoledronic acid |
5.41 | 12669777 |
MESH:D007006 |
Hypogonadism |
|
Iron |
3.83 | 16640825 |
MESH:D007037 |
Hypothyroidism |
|
Iron |
4.33 | 16640825 |
MESH:D020244 |
Infarction, Middle Cerebral Artery |
|
resveratrol |
3.90 | 17600658 |
MESH:D007248 |
Infertility, Male |
|
Lead |
11.72 | 16780224 |
MESH:D007248 |
Infertility, Male |
|
Methylnitrosourea |
11.72 | 7193160 |
MESH:D007248 |
Infertility, Male |
|
Parathion |
11.72 | 16029889 |
MESH:D007248 |
Infertility, Male |
|
sodium arsenite |
11.72 | 12646999 15346721 |
MESH:D007249 |
Inflammation |
|
Flurbiprofen |
6.05 | 11099482 |
MESH:D007249 |
Inflammation |
|
resveratrol |
6.05 | 16366677 |
MESH:D007249 |
Inflammation |
|
Tetradecanoylphorbol Acetate |
6.05 | 7812673 7562506 8273558 11698051 15177302 |
MESH:D007251 |
Influenza, Human |
|
Quercetin |
20.30 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
resveratrol |
20.30 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
20.30 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
20.30 | 16624496 |
MESH:D007333 |
Insulin Resistance |
|
Estradiol |
2.43 | 16627594 16393666 |
MESH:D007410 |
Intestinal Diseases |
|
Superoxides |
4.70 | 10210152 |
MESH:D019189 |
Iron Metabolism Disorders |
|
Iron |
4.32 | 17163184 |
MESH:D007627 |
Keloid |
|
Quercetin |
4.21 | 17086741 |
MESH:D007673 |
Kidney Cortex Necrosis |
|
Cisplatin |
4.36 | 15464296 |
MESH:D007674 |
Kidney Diseases |
|
2-dichlorobenzene |
25.23 | 8440869 |
MESH:D007674 |
Kidney Diseases |
|
Cisplatin |
25.23 | 12649298 19839026 12231392 15190930 18289764 |
MESH:D007674 |
Kidney Diseases |
|
Doxorubicin |
25.23 | 15699352 16775033 15369732 |
MESH:D007674 |
Kidney Diseases |
|
Estradiol |
25.23 | 15618244 |
MESH:D007674 |
Kidney Diseases |
|
Mercury |
25.23 | 17934191 |
MESH:D007674 |
Kidney Diseases |
|
Quercetin |
25.23 | 16962696 |
MESH:D007674 |
Kidney Diseases |
|
sodium arsenite |
25.23 | 20008137 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
25.23 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Copper |
18.21 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Doxorubicin |
18.21 | 16707910 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Hydrogen Peroxide |
18.21 | 16518626 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
18.21 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
2,4-dinitrotoluene |
16.64 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
2,6-dinitrotoluene |
16.64 | 16705839 |
MESH:D007680 |
Kidney Neoplasms |
|
Estradiol |
16.64 | 15610895 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
16.64 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
16.64 | 16985049 |
MESH:D007683 |
Kidney Tubular Necrosis, Acute |
|
Cisplatin |
4.02 | 11231351 |
MESH:D007855 |
Lead Poisoning |
|
Lead |
5.16 | 16700817 |
MESH:D007859 |
Learning Disorders |
|
Copper |
7.95 | 17134702 |
MESH:D007859 |
Learning Disorders |
|
Lead |
7.95 | 16384672 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
4.99 | 15070760 |
MESH:D007938 |
Leukemia |
|
Quercetin |
4.99 | 17468513 |
MESH:D004915 |
Leukemia, Erythroblastic, Acute |
|
Doxorubicin |
4.38 | 16085563 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
7.67 | 17077332 12560223 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
zoledronic acid |
7.67 | 18089816 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
3.54 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
2.83 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.07 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
1.98 | 20471514 16467208 17050201 19850784 16968895 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
5.97 | 17107899 17869043 11468182 12018890 16112521 15622746 19075265 16331271 16823087 15748426 16891316 15336539 9834237 17217047 17649720 16330433 15213294 16966277 12712474 12679006 19035177 11161223 19642359 19225113 17712046 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
resveratrol |
5.97 | 16087638 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
3.62 | 16882451 |
MESH:D020961 |
Lewy Body Disease |
|
Iron |
4.68 | 16563566 |
MESH:D017880 |
Limb Deformities, Congenital |
|
Methylnitrosourea |
3.62 | 15526292 |
MESH:D008103 |
Liver Cirrhosis |
|
Carbon Tetrachloride |
5.34 | 16221502 16943688 17174718 11408273 17334410 17157831 16239168 21278145 11903743 |
MESH:D008103 |
Liver Cirrhosis |
|
Iron |
5.34 | 16640825 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
bicyclol |
10.51 | 16603200 15730626 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Carbon Tetrachloride |
10.51 | 18006644 15876570 16248980 12958196 14716496 12667390 12649538 16011737 18395914 16192424 15925388 18156304 15931870 18263696 17922224 14716833 12389079 17766677 18412020 16027843 15338365 13678700 17708605 15052691 16638106 18395095 16015684 18187930 17805973 18317297 12632514 16033810 14620537 14512876 17761835 16097048 17481882 18429990 18054572 15362042 12445418 12445421 18472332 15650968 17869086 17900296 16136751 18166357 15730626 17631135 14748882 18339082 15673190 17944888 17698563 18420326 18210741 17823541 18472094 15893842 18277467 12609069 18251166 18205269 17557913 15057751 17714472 17565644 12741479 10355542 12898905 18279442 15818738 20821823 12546737 17640975 18376398 15996030 12586293 15123356 12632512 12666154 18481824 17976157 18705752 14724832 15959796 15370692 17525996 16116963 18418968 17721639 11481614 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Doxorubicin |
10.51 | 16439617 16595196 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
epigallocatechin gallate |
10.51 | 17481882 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Estradiol |
10.51 | 14716833 14659978 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
farnesylthiosalicylic acid |
10.51 | 15288472 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Quercetin |
10.51 | 12741479 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
10.51 | 16169303 |
MESH:D008107 |
Liver Diseases |
|
2-dichlorobenzene |
5.44 | 1949037 8440869 1853346 8661352 |
MESH:D008107 |
Liver Diseases |
|
Carbon Tetrachloride |
5.44 | 16246199 16964402 17285989 15830285 15720792 |
MESH:D008107 |
Liver Diseases |
|
limonene |
5.44 | 1715830 |
MESH:D008108 |
Liver Diseases, Alcoholic |
|
Iron |
4.26 | 16737972 17207112 |
MESH:D017093 |
Liver Failure |
|
Carbon Tetrachloride |
3.42 | 15123358 |
MESH:D017114 |
Liver Failure, Acute |
|
Carbon Tetrachloride |
3.01 | 16899240 14706259 |
MESH:D008113 |
Liver Neoplasms |
|
2,6-dinitrotoluene |
49.10 | 7678174 |
MESH:D008113 |
Liver Neoplasms |
|
2-Acetylaminofluorene |
49.10 | 10672840 10737359 16273603 11376686 18001218 14678523 |
MESH:D008113 |
Liver Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
49.10 | 9643874 |
MESH:D008113 |
Liver Neoplasms |
|
Aflatoxin B1 |
49.10 | 2125692 18177683 9163691 15890375 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
49.10 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Benzo(a)pyrene |
49.10 | 21137059 20195826 |
MESH:D008113 |
Liver Neoplasms |
|
Butylated Hydroxytoluene |
49.10 | 18177683 |
MESH:D008113 |
Liver Neoplasms |
|
Carbon Tetrachloride |
49.10 | 19294768 |
MESH:D008113 |
Liver Neoplasms |
|
Copper |
49.10 | 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
49.10 | 17045692 16603448 15113037 18383874 |
MESH:D008113 |
Liver Neoplasms |
|
Heptachlor |
49.10 | 9544696 2422723 |
MESH:D008113 |
Liver Neoplasms |
|
Iron |
49.10 | 16640825 20302851 |
MESH:D008113 |
Liver Neoplasms |
|
Quercetin |
49.10 | 18980244 |
MESH:D008113 |
Liver Neoplasms |
|
resveratrol |
49.10 | 19321006 19812893 19073162 20405173 |
MESH:D008113 |
Liver Neoplasms |
|
sodium arsenite |
49.10 | 16712894 15276417 |
MESH:D008113 |
Liver Neoplasms |
|
Urethane |
49.10 | 17559639 16391232 17093202 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2,6-dinitrotoluene |
24.06 | 6135515 2876784 2876786 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
2-Acetylaminofluorene |
24.06 | 6150874 1399818 534488 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
24.06 | 1399818 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Aflatoxin B1 |
24.06 | 8603461 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
24.06 | 20377131 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Carbon Tetrachloride |
24.06 | 12014681 15583823 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Doxorubicin |
24.06 | 17085340 16842330 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
Quercetin |
24.06 | 19519916 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
2.75 | 15213294 |
MESH:D038061 |
Lower Extremity Deformities, Congenital |
|
Methylnitrosourea |
4.71 | 16080182 |
MESH:D008171 |
Lung Diseases |
|
Acetylcysteine |
17.24 | 12815614 |
MESH:D008171 |
Lung Diseases |
|
Asbestos, Serpentine |
17.24 | 17200189 |
MESH:D008171 |
Lung Diseases |
|
Ozone |
17.24 | 19066396 8266340 |
MESH:D008171 |
Lung Diseases |
|
sodium arsenite |
17.24 | 19095001 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
17.24 | 16863852 |
MESH:D055370 |
Lung Injury |
|
Ozone |
3.12 | 20417186 |
MESH:D008175 |
Lung Neoplasms |
marker/mechanism |
|
| 10779650 11307925 11552296 12765245 |
MESH:D008175 |
Lung Neoplasms |
|
2-Acetylaminofluorene |
63.00 | 11376686 |
MESH:D008175 |
Lung Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
63.00 | 11376689 |
MESH:D008175 |
Lung Neoplasms |
|
Aflatoxin B1 |
63.00 | 14755239 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
63.00 | 19825857 11798837 |
MESH:D008175 |
Lung Neoplasms |
|
Asbestos, Serpentine |
63.00 | 11198217 |
MESH:D008175 |
Lung Neoplasms |
|
Benzo(a)pyrene |
63.00 | 18816296 20064080 20464547 17053015 18569708 6695378 20135361 18520028 20869020 |
MESH:D008175 |
Lung Neoplasms |
|
Beryllium |
63.00 | 9255578 8933044 7545909 9715507 |
MESH:D008175 |
Lung Neoplasms |
|
Butylated Hydroxytoluene |
63.00 | 19925653 11696405 18597497 19359593 16337739 15390079 11246140 |
MESH:D008175 |
Lung Neoplasms |
|
Cisplatin |
63.00 | 6189445 11798837 17225452 |
MESH:D008175 |
Lung Neoplasms |
|
Doxorubicin |
63.00 | 6189445 17418594 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
63.00 | 16019985 6695378 16271038 17703301 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
63.00 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Iron |
63.00 | 16640825 |
MESH:D008175 |
Lung Neoplasms |
|
Methylnitrosourea |
63.00 | 18062963 |
MESH:D008175 |
Lung Neoplasms |
|
Ozone |
63.00 | 8597069 7614698 |
MESH:D008175 |
Lung Neoplasms |
|
Plutonium |
63.00 | 9255578 |
MESH:D008175 |
Lung Neoplasms |
|
Quercetin |
63.00 | 16280456 |
MESH:D008175 |
Lung Neoplasms |
|
sodium arsenite |
63.00 | 16712894 15276417 19931552 17077188 17306315 |
MESH:D008175 |
Lung Neoplasms |
|
Sulfur Dioxide |
63.00 | 20064080 |
MESH:D008175 |
Lung Neoplasms |
|
Tetradecanoylphorbol Acetate |
63.00 | 11807781 |
MESH:D008175 |
Lung Neoplasms |
|
Tetranitromethane |
63.00 | 14713543 9255578 |
MESH:D008175 |
Lung Neoplasms |
|
tipifarnib |
63.00 | 16885199 |
MESH:D008175 |
Lung Neoplasms |
|
Urethane |
63.00 | 12957351 16337739 11893704 11062179 16289808 17093202 15166089 11246140 11544531 15136453 6695378 17195641 17255336 11307925 12466968 11497255 10997738 12117781 15902970 16007126 12765245 11074608 11807781 10779650 11323394 10530776 16926031 11552296 10822126 11992545 16204055 14587096 7750092 16788158 16391232 |
MESH:D008175 |
Lung Neoplasms |
|
Vehicle Emissions |
63.00 | 9255578 |
MESH:D008175 |
Lung Neoplasms |
|
Vincristine |
63.00 | 19825857 6189445 |
MESH:D008175 |
Lung Neoplasms |
|
vinyl carbamate |
63.00 | 11134547 12765245 17361011 16885199 12438228 14755239 15824018 16247444 15172992 17363558 12117777 11195469 17163412 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
63.00 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
4.03 | 15086387 |
MESH:D008223 |
Lymphoma |
|
9,10-Dimethyl-1,2-benzanthracene |
13.27 | 11376689 |
MESH:D008223 |
Lymphoma |
|
Doxorubicin |
13.27 | 16098063 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
13.27 | 15790496 |
MESH:D008223 |
Lymphoma |
|
Methylnitrosourea |
13.27 | 16257854 11418001 |
MESH:D016393 |
Lymphoma, B-Cell |
|
Methylnitrosourea |
8.18 | 14633661 |
MESH:D016393 |
Lymphoma, B-Cell |
|
resveratrol |
8.18 | 17088997 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
Doxorubicin |
6.75 | 17654614 |
MESH:D008228 |
Lymphoma, Non-Hodgkin |
|
resveratrol |
6.75 | 14749477 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Doxorubicin |
9.21 | 15621674 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
9.21 | 15375218 |
MESH:D008268 |
Macular Degeneration |
|
Iron |
3.50 | 16640825 |
MESH:D015674 |
Mammary Neoplasms, Animal |
|
resveratrol |
3.49 | 15688416 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
marker/mechanism |
|
| 11376698 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
9,10-Dimethyl-1,2-benzanthracene |
36.44 | 18840765 16153821 1500032 8985016 16082771 11807958 10697514 12844480 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Butylated Hydroxytoluene |
36.44 | 1500032 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Doxorubicin |
36.44 | 15458769 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Estradiol |
36.44 | 11807958 16891317 11408345 17203775 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
36.44 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Methylnitrosourea |
36.44 | 10767621 14999141 11751437 16827153 15113128 17020996 15313902 19196723 11807958 16051031 16619500 16944150 17131329 15688392 10838139 12931682 14633655 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
resveratrol |
36.44 | 11606380 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
36.44 | 15318939 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Tetradecanoylphorbol Acetate |
36.44 | 8985016 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
tipifarnib |
36.44 | 16648579 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
zoledronic acid |
36.44 | 17312309 |
MESH:D020149 |
Manganese Poisoning |
|
Estradiol |
3.70 | 19453300 |
MESH:D008545 |
Melanoma |
|
Cisplatin |
14.72 | 18176117 17761969 12393984 18505091 11135225 16432458 12883367 17023156 18332650 16248763 12374674 15577323 16809738 |
MESH:D008545 |
Melanoma |
|
docetaxel |
14.72 | 12417787 |
MESH:D008545 |
Melanoma |
|
Doxorubicin |
14.72 | 16827129 |
MESH:D008545 |
Melanoma |
|
epigallocatechin gallate |
14.72 | 11746506 17992120 |
MESH:D008545 |
Melanoma |
|
farnesylthiosalicylic acid |
14.72 | 12535206 |
MESH:D008545 |
Melanoma |
|
Glucose |
14.72 | 14993021 |
MESH:D008545 |
Melanoma |
|
resveratrol |
14.72 | 17992120 |
MESH:D008545 |
Melanoma |
|
sodium arsenite |
14.72 | 16487513 19082730 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Cisplatin |
9.57 | 15990972 |
MESH:D018328 |
Melanoma, Amelanotic |
|
Vincristine |
9.57 | 15990972 |
MESH:D008569 |
Memory Disorders |
|
Lead |
4.44 | 16384672 17263510 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
5.20 | 17943659 |
MESH:D007706 |
Menkes Kinky Hair Syndrome |
|
Copper |
5.12 | 17268249 17109627 |
MESH:D008654 |
Mesothelioma |
|
Cisplatin |
11.44 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Doxorubicin |
11.44 | 17638057 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
11.44 | 15107826 |
MESH:D008654 |
Mesothelioma |
|
zoledronic acid |
11.44 | 16675582 |
MESH:D008659 |
Metabolic Diseases |
|
resveratrol |
3.68 | 17112576 |
MESH:D008679 |
Metaplasia |
|
Ozone |
4.33 | 10496685 |
MESH:D028361 |
Mitochondrial Diseases |
|
Doxorubicin |
3.80 | 15792986 |
MESH:D009062 |
Mouth Neoplasms |
|
Benzo(a)pyrene |
6.49 | 16381670 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
6.49 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Doxorubicin |
4.03 | 17415656 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
12.67 | 19549372 19417148 15949261 11468182 14977855 |
MESH:D009101 |
Multiple Myeloma |
|
lonafarnib |
12.67 | 16996129 |
MESH:D009101 |
Multiple Myeloma |
|
resveratrol |
12.67 | 14749477 16490592 16267019 17049120 17164350 17935668 |
MESH:D009101 |
Multiple Myeloma |
|
zoledronic acid |
12.67 | 19621390 18089719 16996129 |
MESH:D020528 |
Multiple Sclerosis, Chronic Progressive |
|
Iron |
4.89 | 17086897 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
epigallocatechin gallate |
10.09 | 17962980 |
MESH:D009134 |
Muscular Atrophy, Spinal |
|
resveratrol |
10.09 | 17962980 |
MESH:D009181 |
Mycoses |
|
Iron |
4.69 | 16640825 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
3.89 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
2.65 | 16882451 16105982 |
MESH:D009203 |
Myocardial Infarction |
|
Doxorubicin |
10.42 | 19429709 15857846 |
MESH:D009203 |
Myocardial Infarction |
|
Quercetin |
10.42 | 19595682 |
MESH:D009203 |
Myocardial Infarction |
|
resveratrol |
10.42 | 17015251 17188708 16456233 16525036 17125593 16317513 |
MESH:D009203 |
Myocardial Infarction |
|
Vincristine |
10.42 | 17284715 |
MESH:D017202 |
Myocardial Ischemia |
|
Iron |
7.45 | 16604332 |
MESH:D017202 |
Myocardial Ischemia |
|
resveratrol |
7.45 | 17125593 17015251 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Estradiol |
10.83 | 16810080 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Iron |
10.83 | 16604332 |
MESH:D015428 |
Myocardial Reperfusion Injury |
|
Quercetin |
10.83 | 19207477 |
MESH:D009205 |
Myocarditis |
|
resveratrol |
4.00 | 17322642 |
MESH:D009336 |
Necrosis |
|
2,4-dinitrotoluene |
7.82 | 18551238 |
MESH:D009336 |
Necrosis |
|
2,6-dinitrotoluene |
7.82 | 7678174 18551238 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
3.23 | 16624393 |
MESH:D009362 |
Neoplasm Metastasis |
|
Acetylcysteine |
10.60 | 14720322 |
MESH:D009362 |
Neoplasm Metastasis |
|
capecitabine |
10.60 | 12972520 |
MESH:D009362 |
Neoplasm Metastasis |
|
Doxorubicin |
10.60 | 18259882 |
MESH:D009362 |
Neoplasm Metastasis |
|
zoledronic acid |
10.60 | 17312309 19139120 15867366 |
MESH:D009369 |
Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
31.38 | 11544531 |
MESH:D009369 |
Neoplasms |
|
Benzo(a)pyrene |
31.38 | 11141357 |
MESH:D009369 |
Neoplasms |
|
capecitabine |
31.38 | 16374040 |
MESH:D009369 |
Neoplasms |
|
Cisplatin |
31.38 | 16773208 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
31.38 | 18239605 18600527 16928823 |
MESH:D009369 |
Neoplasms |
|
Methylnitrosourea |
31.38 | 15533788 |
MESH:D009369 |
Neoplasms |
|
Nicotine |
31.38 | 16365874 |
MESH:D009369 |
Neoplasms |
|
Nitrofurazone |
31.38 | 15488632 |
MESH:D009369 |
Neoplasms |
|
Quercetin |
31.38 | 15185748 |
MESH:D009369 |
Neoplasms |
|
sodium arsenite |
31.38 | 11559025 |
MESH:D009369 |
Neoplasms |
|
Urethane |
31.38 | 15625555 |
MESH:D009374 |
Neoplasms, Experimental |
|
Asbestos, Serpentine |
25.84 | 11704859 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
25.84 | 16707424 |
MESH:D009374 |
Neoplasms, Experimental |
|
Methylnitrosourea |
25.84 | 12696579 |
MESH:D009374 |
Neoplasms, Experimental |
|
resveratrol |
25.84 | 8985016 |
MESH:D009374 |
Neoplasms, Experimental |
|
sodium arsenite |
25.84 | 20056578 |
MESH:D009374 |
Neoplasms, Experimental |
|
Urethane |
25.84 | 15582191 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Copper |
12.80 | 17308104 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Estradiol |
12.80 | 17289903 |
MESH:D009389 |
Neovascularization, Pathologic |
|
Nicotine |
12.80 | 16365874 |
MESH:D009395 |
Nephritis, Interstitial |
|
Cisplatin |
3.72 | 15464296 |
MESH:D009401 |
Nephrosis |
|
Doxorubicin |
4.02 | 16899518 16636307 |
MESH:D009404 |
Nephrotic Syndrome |
|
Doxorubicin |
7.56 | 15640375 16889571 |
MESH:D009404 |
Nephrotic Syndrome |
|
Iron |
7.56 | 17178036 |
MESH:D009410 |
Nerve Degeneration |
|
Rotenone |
3.27 | 15790535 18619942 17356569 |
MESH:D009421 |
Nervous System Malformations |
|
Estradiol |
2.93 | 11399458 16427766 |
MESH:D009436 |
Neural Tube Defects |
|
Acetylcysteine |
9.13 | 19446573 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
9.13 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
sodium arsenite |
9.13 | 12854658 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
10.75 | 16003739 17160924 16651423 |
MESH:D009442 |
Neurilemmoma |
|
Methylnitrosourea |
10.75 | 11555667 |
MESH:D009447 |
Neuroblastoma |
|
Cisplatin |
5.61 | 8761367 |
MESH:D009447 |
Neuroblastoma |
|
Doxorubicin |
5.61 | 15555623 |
MESH:D019636 |
Neurodegenerative Diseases |
|
Iron |
6.73 | 17296847 16604332 |
MESH:D019636 |
Neurodegenerative Diseases |
|
resveratrol |
6.73 | 17652729 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Cisplatin |
9.29 | 8761367 |
MESH:D017599 |
Neuroectodermal Tumors |
|
Vincristine |
9.29 | 12837982 |
MESH:D020078 |
Neurogenic Inflammation |
|
Quercetin |
8.33 | 17929310 |
MESH:D020078 |
Neurogenic Inflammation |
|
resveratrol |
8.33 | 17929310 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
6.68 | 16436463 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Malathion |
6.68 | 15081274 |
MESH:D009634 |
Noonan Syndrome |
marker/mechanism |
|
| 17703371 |
MESH:D009784 |
Occupational Diseases |
|
2,4-dinitrotoluene |
6.65 | 12819281 16049721 |
MESH:D009784 |
Occupational Diseases |
|
2,6-dinitrotoluene |
6.65 | 16049721 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
5.20 | 17160924 |
MESH:D010003 |
Osteoarthritis |
|
Iron |
3.46 | 16640825 |
MESH:D010014 |
Osteolysis |
|
zoledronic acid |
4.61 | 15867366 |
MESH:D010024 |
Osteoporosis |
|
Iron |
6.05 | 16640825 16648989 |
MESH:D010024 |
Osteoporosis |
|
zoledronic acid |
6.05 | 17882678 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
Quercetin |
7.84 | 19495926 |
MESH:D015663 |
Osteoporosis, Postmenopausal |
|
resveratrol |
7.84 | 17513867 |
MESH:D012516 |
Osteosarcoma |
|
Doxorubicin |
3.48 | 15930896 |
MESH:D010051 |
Ovarian Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
21.44 | 16891317 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
21.44 | 19769630 16624393 12452020 |
MESH:D010051 |
Ovarian Neoplasms |
|
Cisplatin |
21.44 | 19769630 6897625 17225452 15464296 |
MESH:D010051 |
Ovarian Neoplasms |
|
Estradiol |
21.44 | 19401270 |
MESH:D010051 |
Ovarian Neoplasms |
|
Nitrofurazone |
21.44 | 11026599 |
MESH:D010051 |
Ovarian Neoplasms |
|
Quercetin |
21.44 | 19005980 |
MESH:D010051 |
Ovarian Neoplasms |
|
sodium arsenite |
21.44 | 15276417 17306315 |
MESH:D010051 |
Ovarian Neoplasms |
|
Urethane |
21.44 | 16391232 |
MESH:D010146 |
Pain |
|
zoledronic acid |
3.34 | 16475674 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
15.90 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Cisplatin |
15.90 | 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
15.90 | 16500647 16929163 15113037 19003803 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Methylnitrosourea |
15.90 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Quercetin |
15.90 | 16965848 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Tetradecanoylphorbol Acetate |
15.90 | 15976015 |
MESH:D010212 |
Papilloma |
marker/mechanism |
|
| 8330346 |
MESH:D010212 |
Papilloma |
|
9,10-Dimethyl-1,2-benzanthracene |
16.22 | 15173996 17234724 16517061 |
MESH:D010212 |
Papilloma |
|
Hydrogen Peroxide |
16.22 | 12065085 |
MESH:D010212 |
Papilloma |
|
Iron |
16.22 | 12065085 |
MESH:D010212 |
Papilloma |
|
Tetradecanoylphorbol Acetate |
16.22 | 8330346 12065085 18404319 18922899 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
3.45 | 19927285 |
MESH:D020447 |
Parasomnias |
|
Iron |
5.24 | 17352947 |
MESH:D010300 |
Parkinson Disease |
|
Iron |
4.57 | 16563566 16640825 |
MESH:D010300 |
Parkinson Disease |
|
Rotenone |
4.57 | 19114014 18619942 11445065 19232380 11535288 18191903 15451049 16412576 16140633 |
MESH:D020734 |
Parkinsonian Disorders |
|
Rotenone |
3.41 | 15927086 18197244 15795934 15574749 |
MESH:D010523 |
Peripheral Nervous System Diseases |
|
Cisplatin |
3.58 | 15464296 |
MESH:D010538 |
Peritonitis |
|
Ozone |
3.39 | 16369182 |
MESH:D003557 |
Phyllodes Tumor |
|
Doxorubicin |
4.38 | 17983394 |
MESH:D010900 |
Pituitary Diseases |
|
Iron |
4.89 | 16604332 |
MESH:D010911 |
Pituitary Neoplasms |
|
Urethane |
4.67 | 16391232 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
4.11 | 15087411 |
MESH:D010995 |
Pleural Diseases |
|
Asbestos, Serpentine |
4.94 | 10923243 |
MESH:D010997 |
Pleural Neoplasms |
|
Cisplatin |
11.35 | 17638057 |
MESH:D010997 |
Pleural Neoplasms |
|
Doxorubicin |
11.35 | 17638057 |
MESH:D011014 |
Pneumonia |
|
Butylated Hydroxytoluene |
8.80 | 11893704 |
MESH:D011014 |
Pneumonia |
|
Ozone |
8.80 | 18007984 18929643 18381685 |
MESH:D011041 |
Poisoning |
|
Iron |
3.59 | 16604332 |
MESH:D011085 |
Polycystic Ovary Syndrome |
|
Glycosylation End Products, Advanced |
5.39 | 17201808 |
MESH:D017119 |
Porphyria Cutanea Tarda |
|
Iron |
4.25 | 16640825 |
MESH:D011230 |
Precancerous Conditions |
|
Quercetin |
3.33 | 19056647 |
MESH:D054198 |
Precursor Cell Lymphoblastic Leukemia-Lymphoma |
|
Vincristine |
4.14 | 21297632 |
MESH:D011225 |
Pre-Eclampsia |
|
Iron |
3.81 | 16640825 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Lead |
7.82 | 16384672 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
resveratrol |
7.82 | 16679765 |
MESH:D019048 |
Prostatic Intraepithelial Neoplasia |
|
Estradiol |
3.19 | 20887781 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
8.60 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
Benzo(a)pyrene |
8.60 | 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
Copper |
8.60 | 17308104 17079463 |
MESH:D011471 |
Prostatic Neoplasms |
|
docetaxel |
8.60 | 18824434 16644109 16520278 19103299 |
MESH:D011471 |
Prostatic Neoplasms |
|
Doxorubicin |
8.60 | 16888761 15897917 16868541 18437689 15749863 16729912 |
MESH:D011471 |
Prostatic Neoplasms |
|
Estradiol |
8.60 | 16740699 |
MESH:D011471 |
Prostatic Neoplasms |
|
farnesylthiosalicylic acid |
8.60 | 16780807 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
8.60 | 19082440 18626508 |
MESH:D011471 |
Prostatic Neoplasms |
|
Flurbiprofen |
8.60 | 17409433 |
MESH:D011471 |
Prostatic Neoplasms |
|
Heptachlor |
8.60 | 12661182 |
MESH:D011471 |
Prostatic Neoplasms |
|
Methylnitrosourea |
8.60 | 15682402 12376480 |
MESH:D011471 |
Prostatic Neoplasms |
|
Quercetin |
8.60 | 14715546 17292933 |
MESH:D011471 |
Prostatic Neoplasms |
|
resveratrol |
8.60 | 17675339 17718901 17636462 16731767 17804756 15767336 |
MESH:D011471 |
Prostatic Neoplasms |
|
sodium arsenite |
8.60 | 16039940 |
MESH:D011471 |
Prostatic Neoplasms |
|
theaflavin |
8.60 | 17499812 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
8.60 | 15084515 |
MESH:D011471 |
Prostatic Neoplasms |
|
zoledronic acid |
8.60 | 19103299 12438248 |
MESH:D011528 |
Protozoan Infections |
|
Iron |
5.24 | 16640825 |
MESH:D011658 |
Pulmonary Fibrosis |
|
Asbestos, Serpentine |
3.48 | 15511213 18569384 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
3.35 | 15538739 16160472 18722050 18286688 |
MESH:D000608 |
Renal Aminoacidurias |
|
Mercuric Chloride |
5.32 | 2918855 |
MESH:D051437 |
Renal Insufficiency |
|
Cisplatin |
7.91 | 15464296 |
MESH:D051437 |
Renal Insufficiency |
|
Doxorubicin |
7.91 | 17922066 |
MESH:D051436 |
Renal Insufficiency, Chronic |
|
resveratrol |
4.80 | 16325855 |
MESH:D015427 |
Reperfusion Injury |
|
resveratrol |
5.88 | 16314181 17520802 17058453 15827377 16317513 |
MESH:D015427 |
Reperfusion Injury |
|
Superoxides |
5.88 | 18460982 |
MESH:D012120 |
Respiration Disorders |
|
Chlorine |
4.43 | 18579056 |
MESH:D012128 |
Respiratory Distress Syndrome, Adult |
|
Acetylcysteine |
3.82 | 12210543 |
MESH:D012135 |
Respiratory Sounds |
|
Malathion |
12.32 | 11874814 17119214 |
MESH:D012135 |
Respiratory Sounds |
|
Parathion |
12.32 | 11874814 17119214 |
MESH:D012135 |
Respiratory Sounds |
|
Vehicle Emissions |
12.32 | 18950799 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Malathion |
8.93 | 17119214 |
MESH:D012140 |
Respiratory Tract Diseases |
|
Parathion |
8.93 | 17119214 |
MESH:D012148 |
Restless Legs Syndrome |
|
Iron |
3.94 | 16930377 |
MESH:D012162 |
Retinal Degeneration |
|
Methylnitrosourea |
3.81 | 18155124 18172121 |
MESH:D012175 |
Retinoblastoma |
|
Methylnitrosourea |
4.72 | 11555667 |
MESH:D012509 |
Sarcoma |
|
Doxorubicin |
3.32 | 18313854 16767912 15675481 15625365 17710206 17203757 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
18.69 | 16646077 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Cisplatin |
18.69 | 14601052 |
MESH:D012512 |
Sarcoma, Ewing's |
|
Doxorubicin |
18.69 | 14601052 16326096 |
MESH:D012512 |
Sarcoma, Ewing's |
|
zoledronic acid |
18.69 | 16121404 |
MESH:D012514 |
Sarcoma, Kaposi |
|
Doxorubicin |
4.03 | 17846226 |
MESH:D012554 |
Schistosomiasis japonica |
|
Quercetin |
4.77 | 16862918 |
MESH:D012559 |
Schizophrenia |
|
Copper |
2.96 | 16842975 |
MESH:D012640 |
Seizures |
|
2,4-dinitrotoluene |
6.75 | 18551238 |
MESH:D012640 |
Seizures |
|
2,6-dinitrotoluene |
6.75 | 18551238 |
MESH:D012640 |
Seizures |
|
Nicotine |
6.75 | 17873105 |
MESH:D018239 |
Seminoma |
marker/mechanism |
|
| 19855393 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.19 | 18709164 |
MESH:D012878 |
Skin Neoplasms |
marker/mechanism |
|
| 8330346 18758463 15958052 |
MESH:D012878 |
Skin Neoplasms |
|
9,10-Dimethyl-1,2-benzanthracene |
32.66 | 15173996 11376689 16517061 8985016 |
MESH:D012878 |
Skin Neoplasms |
|
Benzo(a)pyrene |
32.66 | 10029692 19755658 |
MESH:D012878 |
Skin Neoplasms |
|
Doxorubicin |
32.66 | 15692506 |
MESH:D012878 |
Skin Neoplasms |
|
Glucose |
32.66 | 14993021 |
MESH:D012878 |
Skin Neoplasms |
|
Hydrogen Peroxide |
32.66 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
Iron |
32.66 | 12065085 |
MESH:D012878 |
Skin Neoplasms |
|
resveratrol |
32.66 | 8985016 15837718 |
MESH:D012878 |
Skin Neoplasms |
|
sodium arsenite |
32.66 | 18572023 19524636 |
MESH:D012878 |
Skin Neoplasms |
|
Tetradecanoylphorbol Acetate |
32.66 | 18404319 12065085 8330346 8985016 11807781 |
MESH:D012878 |
Skin Neoplasms |
|
Urethane |
32.66 | 11807781 |
MESH:D055752 |
Small Cell Lung Carcinoma |
|
Cisplatin |
4.56 | 15464296 |
MESH:D012983 |
Soft Tissue Neoplasms |
|
Doxorubicin |
3.82 | 17203757 15625365 16767912 |
MESH:D016135 |
Spinal Dysraphism |
|
sodium arsenite |
3.18 | 12854658 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
8.40 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Benzo(a)pyrene |
8.40 | 20155912 2093021 |
MESH:D013274 |
Stomach Neoplasms |
|
Cisplatin |
8.40 | 17522103 18396642 15958060 |
MESH:D013274 |
Stomach Neoplasms |
|
docetaxel |
8.40 | 16557585 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
8.40 | 19084572 18396642 16951190 16424979 19015929 17522103 17172411 15786421 18567086 17498489 |
MESH:D013274 |
Stomach Neoplasms |
|
Methylnitrosourea |
8.40 | 16257854 15930296 18593901 |
MESH:D013274 |
Stomach Neoplasms |
|
S 1 (combination) |
8.40 | 18553229 16557585 18506536 |
MESH:D013276 |
Stomach Ulcer |
|
Acetylcysteine |
3.34 | 17918041 |
MESH:D020521 |
Stroke |
|
Vitamin E |
2.90 | 16517955 |
OMIM:601367 |
STROKE, ISCHEMIC |
|
resveratrol |
3.80 | 16321402 |
MESH:D013398 |
Sudden Infant Death |
|
Iron |
4.68 | 16640825 |
MESH:D015173 |
Supratentorial Neoplasms |
|
Vincristine |
5.11 | 12837982 |
MESH:D013736 |
Testicular Neoplasms |
|
Cisplatin |
3.92 | 15464296 17225452 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
9.77 | 15790496 |
MESH:D013953 |
Thymus Neoplasms |
|
Methylnitrosourea |
9.77 | 11418001 |
OMIM:188470 |
THYROID CARCINOMA, FOLLICULAR |
marker/mechanism |
|
| |
MESH:D013964 |
Thyroid Neoplasms |
marker/mechanism |
|
| 3078959 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
8.65 | 19014326 |
MESH:D013964 |
Thyroid Neoplasms |
|
Doxorubicin |
8.65 | 17909728 16010429 |
MESH:D013964 |
Thyroid Neoplasms |
|
Methylnitrosourea |
8.65 | 7505956 3078959 |
MESH:D013978 |
Tibial Fractures |
|
Estradiol |
3.91 | 19048282 |
OMIM:188890 |
TOBACCO ADDICTION, SUSCEPTIBILITY TO |
|
Nicotine |
4.14 | 16785264 16720336 11259349 |
MESH:D014029 |
Tobacco Use Disorder |
|
Nicotine |
4.70 | 15735609 18041664 17979512 18305452 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
7.74 | 16280240 |
MESH:D014062 |
Tongue Neoplasms |
|
resveratrol |
7.74 | 16227395 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
3.20 | 15213294 |
MESH:D014202 |
Tremor |
|
Lead |
4.72 | 21145352 |
MESH:D014376 |
Tuberculosis |
|
Iron |
3.56 | 16597321 |
MESH:D001749 |
Urinary Bladder Neoplasms |
marker/mechanism |
|
| 15958052 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,4-dinitrotoluene |
29.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2,6-dinitrotoluene |
29.31 | 16049721 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
2-Acetylaminofluorene |
29.31 | 1399818 15289314 15867355 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
29.31 | 12973940 20435036 12845720 11780464 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Benzo(a)pyrene |
29.31 | 17053015 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Cisplatin |
29.31 | 12973940 17225452 15464296 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Doxorubicin |
29.31 | 17653716 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Quercetin |
29.31 | 16720314 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
sodium arsenite |
29.31 | 11723127 16712894 17306315 16452187 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
Vehicle Emissions |
29.31 | 11144890 |
MESH:D014571 |
Urologic Neoplasms |
|
2,4-dinitrotoluene |
9.45 | 10091137 |
MESH:D014571 |
Urologic Neoplasms |
|
2,6-dinitrotoluene |
9.45 | 10091137 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Cisplatin |
17.14 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
17.14 | 16803524 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
resveratrol |
17.14 | 17473185 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
sodium arsenite |
17.14 | 11813266 |
MESH:D014594 |
Uterine Neoplasms |
|
resveratrol |
3.41 | 17044934 |
MESH:D014625 |
Vaginal Neoplasms |
|
Cisplatin |
3.86 | 15577323 |
MESH:D014652 |
Vascular Diseases |
|
sodium arsenite |
3.66 | 17056641 |
MESH:D019043 |
Vascular Neoplasms |
|
Urethane |
5.13 | 10620525 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
Doxorubicin |
7.87 | 17678736 16364871 17334414 17638931 |
MESH:D018487 |
Ventricular Dysfunction, Left |
|
resveratrol |
7.87 | 17488730 |
MESH:D014839 |
Vomiting |
|
Cisplatin |
3.94 | 11897121 |
MESH:D014947 |
Wounds and Injuries |
|
Estrogens |
7.50 | 11172683 |
MESH:D014947 |
Wounds and Injuries |
|
Nitrofurazone |
7.50 | 18440737 18222664 |